{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T10:07:10Z","timestamp":1784542030182,"version":"3.55.0"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,7,20]]},"DOI":"10.7759\/cureus.112996","type":"journal-article","created":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T09:35:31Z","timestamp":1784540131000},"source":"Crossref","is-referenced-by-count":0,"title":["Small Bowel Perforation as an Initial Manifestation of Immune Deficiency and Dysregulation-Associated Lymphoma in a Patient With Rheumatoid Arthritis: A Case Report"],"prefix":"10.7759","author":[{"given":"Chisa","family":"Shibata","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoya","family":"Sasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seiichiro","family":"Tada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masato","family":"Maeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.24287","article-title":"Population-based study of autoimmune conditions and the risk of specific lymphoid malignancies","volume":"125","author":"Anderson LA","year":"2009","unstructured":"Anderson LA, Gadalla S, Morton LM, et al.. Population-based study of autoimmune conditions and the risk of specific lymphoid malignancies. Int J Cancer. 2009, 125:398-405. 10.1002\/ijc.24287","journal-title":"Int J Cancer"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199305063281806","article-title":"Brief report: reversible lymphomas associated with Epstein-Barr virus occurring during methotrexate therapy for rheumatoid arthritis and dermatomyositis","volume":"328","author":"Kamel OW","year":"1993","unstructured":"Kamel OW, van de Rijn M, Weiss LM, et al.. Brief report: reversible lymphomas associated with Epstein-Barr virus occurring during methotrexate therapy for rheumatoid arthritis and dermatomyositis. N Engl J Med. 1993, 328:1317-21. 10.1056\/NEJM199305063281806","journal-title":"N Engl J Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-022-01620-2","article-title":"The 5th edition of the World Health Organization classification of haematolymphoid tumours: lymphoid neoplasms","volume":"36","author":"Alaggio R","year":"2022","unstructured":"Alaggio R, Amador C, Anagnostopoulos I, et al.. The 5th edition of the World Health Organization classification of haematolymphoid tumours: lymphoid neoplasms. Leukemia. 2022, 36:1720-48. 10.1038\/s41375-022-01620-2","journal-title":"Leukemia"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1080\/10428194.2017.1369073","article-title":"Clinicopathologic investigation of methotrexate-induced lymphoproliferative disorders, with a focus on regression","volume":"59","author":"Tokuhira M","year":"2018","unstructured":"Tokuhira M, Saito S, Okuyama A, et al.. Clinicopathologic investigation of methotrexate-induced lymphoproliferative disorders, with a focus on regression. Leuk Lymphoma. 2018, 59:1143-52. 10.1080\/10428194.2017.1369073","journal-title":"Leuk Lymphoma"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1996.14.6.1943","article-title":"Spontaneous regression of lymphoproliferative disorders in patients treated with methotrexate for rheumatoid arthritis and other rheumatic diseases","volume":"14","author":"Salloum E","year":"1996","unstructured":"Salloum E, Cooper DL, Howe G, et al.. Spontaneous regression of lymphoproliferative disorders in patients treated with methotrexate for rheumatoid arthritis and other rheumatic diseases. J Clin Oncol. 1996, 14:1943-9. 10.1200\/JCO.1996.14.6.1943","journal-title":"J Clin Oncol"},{"key":"ref6","article-title":"Lymphoproliferative disorders in rheumatoid arthritis: clinicopathological analysis of 76 cases in relation to methotrexate medication","volume":"34","author":"Hoshida Y","year":"2007","unstructured":"Hoshida Y, Xu JX, Fujita S, et al.. Lymphoproliferative disorders in rheumatoid arthritis: clinicopathological analysis of 76 cases in relation to methotrexate medication. J Rheumatol. 2007, 34:322-31.","journal-title":"J Rheumatol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.78960","article-title":"The compression fracture of thoracic spine due to methotrexate-associated lymphoproliferative disorder in rheumatoid arthritis: a case report","volume":"17","author":"Ikuma H","year":"2025","unstructured":"Ikuma H, Hirose T, Nakamura D, Nakamura S, Kawasaki K. The compression fracture of thoracic spine due to methotrexate-associated lymphoproliferative disorder in rheumatoid arthritis: a case report. Cureus. 2025, 17:e78960. 10.7759\/cureus.78960","journal-title":"Cureus"},{"key":"ref8","article-title":"Lymphoma developing in a patient with rheumatoid arthritis taking low dose weekly methotrexate","volume":"18","author":"Ellman MH","year":"1991","unstructured":"Ellman MH, Hurwitz H, Thomas C, et al.. Lymphoma developing in a patient with rheumatoid arthritis taking low dose weekly methotrexate. J Rheumatol. 1991, 18:1741-3.","journal-title":"J Rheumatol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000033083","article-title":"Diffuse large B cell lymphoma CD5-positive arising in an immune deficiency and immune dysregulation setting: a case report and brief review of the literature","volume":"102","author":"Cristian M","year":"2023","unstructured":"Cristian M, Baz RA, Stoica AG, et al.. Diffuse large B cell lymphoma CD5-positive arising in an immune deficiency and immune dysregulation setting: a case report and brief review of the literature. Medicine (Baltimore). 2023, 102:e33083. 10.1097\/MD.0000000000033083","journal-title":"Medicine (Baltimore)"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.36255\/exon-publications.lymphoma.2021","article-title":"","author":"Gallamini A","year":"2021","unstructured":"Gallamini A, Juweid M. Lymphoma . Andrea G, Juweid M (ed): Exon Publications, Australia; 2021. 10.36255\/exon-publications.lymphoma.2021"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.2782-19","article-title":"Gastric perforation due to iatrogenic immunodeficiency-associated lymphoproliferative disorder during the treatment of rheumatoid arthritis","volume":"58","author":"Toyama S","year":"2019","unstructured":"Toyama S, Takatani A, Koga T, et al.. Gastric perforation due to iatrogenic immunodeficiency-associated lymphoproliferative disorder during the treatment of rheumatoid arthritis. Intern Med. 2019, 58:3331-6. 10.2169\/internalmedicine.2782-19","journal-title":"Intern Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1186\/s12957-020-02114-0","article-title":"Cessation of methotrexate and a small intestinal resection provide a good clinical course for a patient with a jejunum perforation induced by a methotrexate-associated lymphoproliferative disorder: a case report","volume":"19","author":"Nomura M","year":"2021","unstructured":"Nomura M, Sumiya R, Ono H, et al.. Cessation of methotrexate and a small intestinal resection provide a good clinical course for a patient with a jejunum perforation induced by a methotrexate-associated lymphoproliferative disorder: a case report. World J Surg Oncol. 2021, 19:4. 10.1186\/s12957-020-02114-0","journal-title":"World J Surg Oncol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.54571","article-title":"Sigmoid colon perforation in diffuse large B-cell lymphoma due to tacrolimus-induced immunodeficiency: a case report","volume":"16","author":"Sakuraba S","year":"2024","unstructured":"Sakuraba S, Nakamura K, Koido K, Hazama H, Ohata K. Sigmoid colon perforation in diffuse large B-cell lymphoma due to tacrolimus-induced immunodeficiency: a case report. Cureus. 2024, 16:e54571. 10.7759\/cureus.54571","journal-title":"Cureus"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1186\/s13000-020-00954-8","article-title":"A case of iatrogenic immunodeficiency-associated colonic lymphoma complicating ulcerative colitis","volume":"15","author":"Suzuki K","year":"2020","unstructured":"Suzuki K, Ohe R, Kabasawa T, et al.. A case of iatrogenic immunodeficiency-associated colonic lymphoma complicating ulcerative colitis. Diagn Pathol. 2020, 15:34. 10.1186\/s13000-020-00954-8","journal-title":"Diagn Pathol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2013-200423","article-title":"EBV-associated colonic B-cell lymphoma following treatment with infliximab for IBD: a new problem?","volume":"2013","author":"Allen PB","year":"2013","unstructured":"Allen PB, Laing G, Connolly A, O'Neill C. EBV-associated colonic B-cell lymphoma following treatment with infliximab for IBD: a new problem?. BMJ Case Rep. 2013, 2013:10.1136\/bcr-2013-200423","journal-title":"BMJ Case Rep"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1002\/hon.2790","article-title":"Association of Epstein-Barr virus with regression after withdrawal of immunosuppressive drugs and subsequent progression of iatrogenic immunodeficiency-associated lymphoproliferative disorders in patients with autoimmune diseases","volume":"38","author":"Fujimoto K","year":"2020","unstructured":"Fujimoto K, Hatanaka KC, Hatanaka Y, et al.. Association of Epstein-Barr virus with regression after withdrawal of immunosuppressive drugs and subsequent progression of iatrogenic immunodeficiency-associated lymphoproliferative disorders in patients with autoimmune diseases. Hematol Oncol. 2020, 38:799-807. 10.1002\/hon.2790","journal-title":"Hematol Oncol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.130270","article-title":"A clinical, pathological, and genetic characterization of methotrexate-associated lymphoproliferative disorders","volume":"41","author":"Yamakawa N","year":"2014","unstructured":"Yamakawa N, Fujimoto M, Kawabata D, et al.. A clinical, pathological, and genetic characterization of methotrexate-associated lymphoproliferative disorders. J Rheumatol. 2014, 41:293-9. 10.3899\/jrheum.130270","journal-title":"J Rheumatol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1182\/blood.v99.11.3909","article-title":"Lymphomas in rheumatoid arthritis patients treated with methotrexate: a 3-year prospective study in France","volume":"99","author":"Mariette X","year":"2002","unstructured":"Mariette X, Cazals-Hatem D, Warszawki J, Liote F, Balandraud N, Sibilia J. Lymphomas in rheumatoid arthritis patients treated with methotrexate: a 3-year prospective study in France. Blood. 2002, 99:3909-15. 10.1182\/blood.v99.11.3909","journal-title":"Blood"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/506700-small-bowel-perforation-as-an-initial-manifestation-of-immune-deficiency-and-dysregulation-associated-lymphoma-in-a-patient-with-rheumatoid-arthritis-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T09:35:32Z","timestamp":1784540132000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/506700-small-bowel-perforation-as-an-initial-manifestation-of-immune-deficiency-and-dysregulation-associated-lymphoma-in-a-patient-with-rheumatoid-arthritis-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,20]]},"references-count":18,"URL":"https:\/\/doi.org\/10.7759\/cureus.112996","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7,20]]}}}